Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Thomas D. Schiano Stories

2014-04-14 23:05:57

Six Mount Sinai Expert Guides use apps and digital content to support a new generation of physicians New York (PRWEB) April 14, 2014 Wiley has teamed up with the Icahn School of Medicine at Mount Sinai, one of the world's leading medical institutions, to create a series of expert guides for medical trainees, research fellows and practicing physicians. The six Mount Sinai Expert Guides combine the expertise of the medical faculty with new online platforms and mobile apps, creating...

2014-04-11 12:57:21

New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV). As part of a compassionate use program, 104 post-liver transplant patients with recurring HCV who had exhausted all treatment options and had poor clinical prognoses, received sofosbuvir (SOF) and ribavirin (RBV) with pegylated interferon (PEG) included at the physicians’ discretion for...

2013-11-04 08:27:35

Presented: November 5, 2013 at the Walter E. Washington Convention Center, Washington, DC WASHINGTON, Nov. 4, 2013 /PRNewswire/ -- For the first time, researchers have been able to prevent the recurrence of hepatitis C virus (HCV) infection in a large proportion of patients (64 percent, n=25/39) who undergo liver transplantation for cirrhosis complicated by hepatocellular carcinoma (HCC). This success was achieved with an interferon-free treatment regimen containing the oral...

2013-10-02 12:29:37

Certification recognizes expertise in liver disease management and transplantation KANSAS CITY, Mo., Oct. 2, 2013 /PRNewswire-USNewswire/ -- The liver transplantation program at Saint Luke's Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid (CMS). The certification is an important step in enhancing the hospital's ability to care for Medicare-covered patients suffering from end-stage liver disease, and attract other insurers who base their...

2013-06-10 12:26:55

Increased use of split livers could significantly increase pediatric organ donor pool, potentially reducing or eliminating waitlist mortality rate for this population BOSTON, June 10, 2013 /PRNewswire-USNewswire/ -- A new study shows that when a liver from a deceased adult or adolescent donor is split into two separate portions for transplantation--with the smaller portion going to a young child and the larger to an adult--the smaller portion used for the child will last just as...

2013-04-09 12:29:04

NORCROSS, Ga., April 9, 2013 /PRNewswire/ -- Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis. The Phase 1 Clinical Trial is entitled, "A Multi-Center, Partially Blinded, Maximum Tolerated...